Velagliflozin proline is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor with antidiabetic activity. Velagliflozin proline reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations[1].
Molecular Weight:
510.58
Purity:
99.43
CAS Number:
[1539295-26-5]
Formula:
C28H34N2O7
Target:
SGLT
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted